Last Updated: 16 June 2026
Dow Inc. (NYSE: DOW) is one of the world's largest materials-science companies, making plastics, industrial intermediates and performance materials from its integrated network of crackers and chemical plants across 29 countries. The investment story today is overwhelmingly cyclical: the global chemicals industry is in one of its deepest downturns in decades, and Dow has spent 2025 and early 2026 cutting costs, idling capacity, halving its dividend and reshaping its portfolio while it waits for margins to recover. Full-year 2025 net sales fell to $40.0 billion and the company posted a GAAP net loss of $2.4 billion, before a first quarter of 2026 in which management said pricing was beginning to inflect upward. This report walks through Dow's segments, financial health, valuation and the risks facing the business, using only figures drawn from the company's own filings and press releases.
1. Company Snapshot
| Field | Value |
|---|---|
| Company | Dow Inc. |
| Ticker / Exchange | DOW (NYSE) |
| Sector | Materials — Commodity & Specialty Chemicals |
| CEO | Jim Fitterling (Chair & CEO; becomes Executive Chair 1 Jul 2026, succeeded as CEO by Karen S. Carter) |
| Headquarters | Midland, Michigan, USA |
| Employees | Approximately 34,600 |
| Revenue (FY2025) | $40.0 billion net sales |
| Net income (FY2025) | Net loss of $2.6 billion available to Dow common stockholders |
| Market cap | ~$24.0 billion (16 Jun 2026) |
| Dividend | $0.35 per quarter ($1.40 annualised) following the mid-2025 cut |
2. Bull & Bear Case
Bull Case
- Deep cyclical trough with recovery optionality: Dow's earnings are near a multi-year low; in past chemical cycles, operating EBITDA has rebounded sharply once supply rationalises and demand recovers, giving significant upside leverage from depressed levels.
- Self-help is landing: Dow delivered more than half of over $6.5 billion of near-term cash and cost-support actions in 2025, and its "Transform to Outperform" programme targets at least $2 billion of additional near-term earnings through radical simplification.
- Advantaged feedstock and asset footprint: Dow's US Gulf Coast shale-advantaged ethylene position and flexible European feedstock slate give it a structural cost edge in polyethylene versus naphtha-based competitors.
- Margins beginning to inflect: Management said the margin backdrop began to positively inflect in March 2026 as global supply constraints emerged, and Q1 2026 free cash flow turned positive at $621 million.
Bear Case
- Prolonged industry downturn: Net sales have fallen every year since 2022 and operating EBIT collapsed to just $0.4 billion in 2025 from $2.6 billion in 2024, with oversupply and weak construction and packaging demand persisting.
- Dividend already cut and still pressured: Dow halved its quarterly dividend to $0.35 in 2025; with negative full-year free cash flow, the payout remains under scrutiny.
- Heavy fixed obligations: Long-term debt has climbed to $17.8 billion, and the company also carries large pension and asbestos-related liabilities that consume cash.
- GAAP losses and impairments: 2025 included a $690 million goodwill impairment in Polyurethanes & Construction Chemicals plus asset write-downs and pension settlement charges, underlining structural pressure in parts of the portfolio.
3. Business Segments
Dow reports across three operating segments. The table below shows each segment's share of FY2025 net sales of $40.0 billion.
| Segment | % of revenue | What it is |
|---|---|---|
| Packaging & Specialty Plastics | 50.0% | Polyethylene, functional polymers and the Hydrocarbons & Energy (merchant olefins) business — Dow's largest and most integrated segment ($20.0bn FY2025 sales). |
| Industrial Intermediates & Infrastructure | 27.9% | Polyurethanes & Construction Chemicals plus Industrial Solutions (glycols, amines, cellulosics) — exposed to building, durables and infrastructure ($11.2bn). |
| Performance Materials & Coatings | 20.4% | Consumer Solutions (silicones) and Coatings & Performance Monomers (acrylics) serving electronics, mobility, personal care and architectural coatings ($8.1bn). |
4. Business Model & Strategy
Integrated, scale-driven cost leadership. Dow's model rests on owning the chemistry from feedstock through to derivatives. Its crackers convert low-cost US ethane and flexible global feedstocks into ethylene and propylene, which are then converted into higher-value polyethylene, polyurethanes, silicones and coatings. This vertical integration is designed to capture margin across the value chain and to give Dow resilience through commodity cycles.
Transform to Outperform. In response to the downturn, Dow has shifted from growth capex toward cash preservation and radical cost simplification. Management is idling and shutting higher-cost upstream assets (including a European cracker idled in 2025 and a US Gulf Coast propylene-oxide unit closed in late 2025), monetising infrastructure (a $2.9 billion sale of a stake in Dow InfraCo), and targeting at least $2 billion of incremental earnings from process re-engineering and stranded-cost removal.
Capital returns through the cycle. Having reset the dividend to a more sustainable $0.35 per quarter, Dow says it intends to prioritise the balance sheet and reinvest in advantaged growth — notably its Path2Zero net-zero cracker project in Alberta, Canada — while restoring higher shareholder returns as margins recover.
5. Financial Health
All figures below are taken from Dow's quarterly earnings press releases and SEC filings. Dow reports in US dollars on a calendar-year basis.
| Fiscal Year | Revenue (net sales) | YoY % | GAAP EPS | Adjusted EPS | Dividend/share | Long-term debt (YE) |
|---|---|---|---|---|---|---|
| 2021 | $54.97bn | — | $8.38 | $8.98 | $2.80 | $14.28bn |
| 2022 | $56.90bn | +3.5% | $6.28 | $6.25 | $2.80 | $14.70bn |
| 2023 | $44.62bn | −21.6% | $0.82 | $2.24 | $2.80 | $14.91bn |
| 2024 | $42.96bn | −3.7% | $1.57 | $1.71 | $2.80 | $15.71bn |
| 2025 | $39.97bn | −7.0% | −$3.70 | −$0.94 | $2.10 | $17.85bn |
Quarterly trend (most recent first). Revenue in US dollars; adjusted EPS is Dow's "operating EPS"; GAAP EPS is diluted loss/earnings per share available to Dow common stockholders.
| Quarter / Half | Revenue | Adjusted EPS | GAAP EPS |
|---|---|---|---|
| Q1 2026 | $9.79bn | −$0.14 | −$0.74 |
| Q4 2025 | $9.46bn | −$0.34 | −$2.15 |
| Q3 2025 | $9.97bn | −$0.19 | $0.08 |
| Q2 2025 | $10.10bn | −$0.42 | −$1.18 |
| Q1 2025 | $10.43bn | $0.02 | −$0.44 |
| FY2025 Total | $39.97bn | −$0.94 | −$3.70 |
The picture is one of a business operating below mid-cycle. Operating EBITDA fell to $3.3 billion in 2025 (from $5.5 billion in 2024), and full-year free cash flow was negative $1.4 billion. Encouragingly, Q1 2026 operating cash flow of $1.1 billion (helped by a NOVA Chemicals litigation payment) lifted free cash flow back to a positive $621 million, and Dow held $4.1 billion of cash at 31 March 2026.
6. Valuation
Raw metrics, June 2026. Not opinions on whether the stock is cheap or expensive.
| Metric | Value |
|---|---|
| Market cap | ~$24.0bn (price ~$33.23 × ~720.7m shares, 16 Jun 2026) |
| Trailing P/E (GAAP) | n/m — Dow reported a GAAP net loss over the trailing twelve months |
| P/E (forward) | n/m — consensus forward earnings are around breakeven as the cycle troughs |
| P/S (TTM) | ~0.61x (market cap ~$24.0bn / TTM net sales ~$39.3bn) |
| P/FCF | n/m — TTM free cash flow was negative (FY2025 FCF −$1.4bn; Q1 2026 FCF turned positive at +$0.62bn) |
| EV/EBITDA (TTM) | ~11.2x (EV ~$35.8bn / TTM operating EBITDA ~$3.19bn; GAAP EBITDA is distorted by 2025 goodwill and asset impairments, so Dow's operating EBITDA is used) |
| Enterprise value | ~$35.8bn (market cap ~$24.0bn + total debt ~$18.1bn − cash & marketable securities ~$6.3bn per 31 Mar 2026 balance sheet) |
| 52-week high | $42.74 |
| 52-week low | $20.40 |
| Short interest (% of float) | ~5.0% of float |
| Days to cover | ~3.2 days (source: Fintel / MarketBeat) |
7. Competitive Position
Dow is one of the three largest chemical producers in the world by revenue, behind Sinopec and BASF and ahead of close polyolefins rival LyondellBasell. Its competitive moat is built on scale, integration and feedstock cost position rather than product differentiation: in commodity grades of polyethylene and polyurethanes, the lowest-cost producer wins, and Dow's US shale-advantaged crackers place it on the favourable end of the global cost curve. The current downturn, however, has compressed that advantage as Chinese capacity additions and weak global demand have driven prices below the level at which even efficient producers earn attractive returns. Dow competes for volume with BASF, LyondellBasell, ExxonMobil Chemical, SABIC, INEOS and Westlake, and in higher-margin silicones and coatings with specialty players such as Wacker, Momentive and Celanese. The decisive variable for Dow's earnings is not market share but the industry-wide spread between feedstock costs and product prices.
8. Peer Comparison
Selected US-listed chemical peers. Market caps as at 16 June 2026; revenue figures are trailing-twelve-month net sales.
| Peer | Market cap (Jun 2026) | Key 2025 metric |
|---|---|---|
| LyondellBasell (LYB) | ~$20.4bn | TTM revenue ~$29.7bn; leading global polyolefins producer |
| Westlake (WLK) | ~$11.2bn | TTM revenue ~$11.0bn; PVC, chlor-alkali and building products |
| Celanese (CE) | ~$5.9bn | TTM revenue ~$9.5bn; acetyls and engineered materials |
| Eastman Chemical (EMN) | ~$8.6bn | TTM revenue ~$8.6bn; specialty additives and materials |
At ~$24bn market cap on ~$39bn of revenue, Dow is the largest of this US peer set and trades around 0.6x sales — a discount typical of commodity-heavy chemical names operating below mid-cycle.
9. Insider Activity
Insider dealing at Dow during 2026 has been dominated by routine director equity grants rather than open-market purchases, and chair and CEO Jim Fitterling — who hands the CEO role to Karen S. Carter on 1 July 2026 — has not been reported buying on the open market. Recent Form 4 filings include time-vested restricted stock and phantom-unit awards to non-executive directors, alongside a cluster of small officer share sales in late February 2026.
| Name | Date | Type | Shares | Price | Value | Plan Type |
|---|---|---|---|---|---|---|
| Luis Alberto Moreno (Director) | 13 Apr 2026 | Grant (RSU) | 5,127 | — | — | Time-vested restricted stock units |
| Wesley G. Bush (Director) | 13 Apr 2026 | Grant (RSU) | 5,127 | — | — | Time-vested RSUs, settled post-service |
| Jeff M. Fettig (Director) | 9 Apr 2026 | Grant (RSU) | 5,127 | — | — | Time-vested RSUs, settled post-service |
| Officers/Director (group) | 26 Feb 2026 | Sale (7 dispositions) | — | — | ~$390,345 total | Open-market / tax-related sales |
10. Risk Factors
- Commodity price & cycle risk (Macro): Dow's earnings swing with the spread between feedstock costs and product prices; a prolonged trough keeps profitability depressed.
- Energy & feedstock volatility (Operational): Spikes in ethane, naphtha and natural-gas costs — including from the Middle East conflict — can compress margins quickly.
- Financial leverage (Financial): Long-term debt of $17.8 billion and $865 million of annual interest expense limit flexibility while earnings are low.
- Dividend sustainability (Financial): The dividend was already halved in 2025; a longer downturn could pressure it further given negative free cash flow.
- Sadara and joint-venture exposure (Financial): Equity losses at Sadara and other JVs, and a guarantee liability on Sadara's project debt, have weighed on results.
- Pension & asbestos liabilities (Financial): Dow carries $4.5 billion of pension/OPEB obligations and $0.6 billion of asbestos-related liabilities that absorb cash.
- Plastics regulation & ESG (Regulatory): Tightening rules on single-use plastics and rising scrutiny of the plastics value chain could affect demand and capex.
- Restructuring execution (Operational): The Transform to Outperform savings depend on management executing significant plant closures and process changes without disrupting customers.
11. Recent Developments
- 23 Apr 2026 — Q1 2026 results. Net sales of $9.8 billion (down 6% year-on-year) and a GAAP loss per share of $0.74, but operating cash flow of $1.1 billion and positive free cash flow of $621 million; management said margins began to inflect upward in March 2026.
- 14 Apr 2026 — CEO succession announced. Dow said Jim Fitterling will become Executive Chair and chief operating officer Karen S. Carter will become Chief Executive Officer, both effective 1 July 2026.
- 29 Jan 2026 — Q4 and full-year 2025 results. Full-year net sales of $40.0 billion and a GAAP net loss of $2.4 billion, including a $690 million goodwill impairment and pension settlement charges; Q4 operating EPS was a loss of $0.34.
- 30 Jul 2025 — Dividend reset. Dow reduced its quarterly dividend to $0.35 per share to preserve cash through the downturn, alongside European portfolio actions and cracker idling.
12. Key Dates & Catalysts
- 1 Jul 2026 — Leadership transition: Karen S. Carter becomes CEO; Jim Fitterling becomes Executive Chair.
- 23 Jul 2026 — Q2 2026 earnings release (announced by the company).
- Expected October 2026 — Q3 2026 results, a key read on whether the March margin inflection is sustaining.
- Expected December 2026 — Year-end update on Transform to Outperform cost savings and progress on the Alberta Path2Zero project.
For live pricing and technical levels, see our Live Charts; track upcoming macro releases on the Economic Calendar; and discuss this research in the ChartsView Forum.
Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.